- Home
- /
- News
- /
- Target Identification/ Validation
- /
- February 2010
Target Identification/ Validation News for February 2010
A genetic link between schizophrenia and autism is enabling researchers to study the effectiveness of drugs used to treat both illnesses.
25 February, 2010
Researchers have discovered a protein crucial in mediating the anti-inflammatory actions of nuclear lipid receptors. The findings create new possibilities for treating metabolic diseases associated with inflammation, such as diabetes.
19 February, 2010
Researchers have uncovered how cells ensure inheritance of their genetic information in order to prevent diseases.
17 February, 2010
Researchers have established a link between deprivation and the p53 gene that explains why women from poorer backgrounds are less likely to survive breast cancer.
16 February, 2010
Scientists working at the University of Dundee have discovered a form of stem cell activity that might help lead to the early identification of cancer.
12 February, 2010
A study in BMC Neuroscience has shown that chocolate-craving mice will tolerate electric shocks to get their fix.
11 February, 2010
Silence Therapeutics announced recently that the United States Patent and Trademark Office has issued them a notice of allowance on a patent application covering a novel cancer target.
10 February, 2010
A centre created by the Medical Research Council (MRC) and MRC Technology to fast-track the discovery and development of novel drugs opened its first call for targets recently.
08 February, 2010